A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 90 peptides from the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
A once-a-month weight drug in development from Amgen: an antibody that blocks the GIP receptor, carrying two GLP-1 peptides that switch the GLP-1 receptor on. In its 52-week phase 2 trial, people without diabetes lost up to about 20% of their weight on average (about 16% counting everyone who stopped), and the curve had not flattened by the end. Commonly reported: in trials, nausea and vomiting around the first doses, easing with a slower start. It is in phase 3 and not approved anywhere.
Sold ready to use, never as a powder you mix, so there’s no mix to work out.
MariTide in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.